Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis
Clinical trial NCT00053417 · COMPLETED
Trial details
- NCT number
- NCT00053417
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2003-12-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.